Equasens Stock

Equasens EBITDA per Employee

The EBITDA per Employee of Equasens (EQS.PA) as of Aug 16, 2026 is 63,044.91 EUR. In the previous year, EBITDA per Employee was 78,520.48 EUR — a change of -19.71% (lower).

EBITDA per Employee

63,044.91EUR

YoY

-19.71%

Last updated:

EBITDA per Employee of Equasens is 2026 63,044.91 EUR. EBITDA per Employee of Equasens was 2025 78,520.48 EUR. It decreases by -19.71% lower compared to the previous year.
Access this data via the Eulerpool API

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

EBITDA per Employee of Equasens is 63,044.91 EUR in 2026.

EBITDA per Employee of Equasens changed from 78,520.48 EUR to 63,044.91 EUR, representing a -19.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Equasens since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Equasens historically and in real time.

Access this data via the Eulerpool API

Workforce — Equasens

All Key Metrics — Equasens